Clinical Trial

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

Study acronym: TARGET-01
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Phase II randomized controlled trial of TKI Alone versus TKI and Local Consolidative Radiation Therapy in oncogene driver mutated oligo metastatic Non-small cell lung cancer patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-03-11; most recent amendment 2025-09-03.
Trial Details
NCT Number NCT05277844
Lead Sponsor Tata Memorial Hospital
Conditions Oligometastatic Disease, Non-small Cell Lung Cancer, Driver Mutation
Enrollment 106 participants
Start Date 2019-11-11
Primary Completion 2026-11-11 (estimated)
Study Completion 2027-11-11 (estimated)
Updated on ClinicalTrials.gov 2025-09-10